Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Experimental mapping of soluble protein domains using a hierarchical approach.
Pedelacq JD, Nguyen HB, Cabantous S, Mark BL, Listwan P, Bell C, Friedland N, Lockard M, Faille A, Mourey L, Terwilliger TC, Waldo GS. Pedelacq JD, et al. Among authors: friedland n. Nucleic Acids Res. 2011 Oct;39(18):e125. doi: 10.1093/nar/gkr548. Epub 2011 Jul 19. Nucleic Acids Res. 2011. PMID: 21771856 Free PMC article.
Author Correction: A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates.
Weidenbacher PA, Sanyal M, Friedland N, Tang S, Arunachalam PS, Hu M, Kumru OS, Morris MK, Fontenot J, Shirreff L, Do J, Cheng YC, Vasudevan G, Feinberg MB, Villinger FJ, Hanson C, Joshi SB, Volkin DB, Pulendran B, Kim PS. Weidenbacher PA, et al. Among authors: friedland n. Nat Commun. 2023 Oct 5;14(1):6211. doi: 10.1038/s41467-023-42061-4. Nat Commun. 2023. PMID: 37798288 Free PMC article. No abstract available.
Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 spike ferritin nanoparticle vaccine antigen produced from two different cell lines.
Kumru OS, Sanyal M, Friedland N, Hickey JM, Joshi R, Weidenbacher P, Do J, Cheng YC, Kim PS, Joshi SB, Volkin DB. Kumru OS, et al. Among authors: friedland n. Vaccine. 2023 Oct 20;41(44):6502-6513. doi: 10.1016/j.vaccine.2023.08.037. Epub 2023 Aug 22. Vaccine. 2023. PMID: 37620203 Free PMC article.
A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates.
Weidenbacher PA, Sanyal M, Friedland N, Tang S, Arunachalam PS, Hu M, Kumru OS, Morris MK, Fontenot J, Shirreff L, Do J, Cheng YC, Vasudevan G, Feinberg MB, Villinger FJ, Hanson C, Joshi SB, Volkin DB, Pulendran B, Kim PS. Weidenbacher PA, et al. Among authors: friedland n. Nat Commun. 2023 Apr 17;14(1):2149. doi: 10.1038/s41467-023-37417-9. Nat Commun. 2023. PMID: 37069151 Free PMC article.
Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 Spike ferritin nanoparticle vaccine antigen produced from two different cell lines.
Kumru OS, Sanyal M, Friedland N, Hickey J, Joshi R, Weidenbacher P, Do J, Cheng YC, Kim PS, Joshi SB, Volkin DB. Kumru OS, et al. Among authors: friedland n. bioRxiv [Preprint]. 2023 Apr 4:2023.04.03.535447. doi: 10.1101/2023.04.03.535447. bioRxiv. 2023. Update in: Vaccine. 2023 Oct 20;41(44):6502-6513. doi: 10.1016/j.vaccine.2023.08.037 PMID: 37066156 Free PMC article. Updated. Preprint.
26 results